Back
Robertet SA Vs. Novo Nordisk AS Industry Stock Comparison
Sell
20
RBTEF
Robertet SA
Last Price:
$890.00
Seasonality Move:
-1.24%
Sell
23
NVO
Novo Nordisk AS
Last Price:
$84.81
Seasonality Move:
6.4%
Sell
20
Robertet SA (RBTEF)
is a Sell
Is Robertet SA a Buy, Sell or Hold?
-
The current Robertet SA [RBTEF] share price is $890.00. The Score for RBTEF is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
RBTEF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.03. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RBTEF Stock Price Chart
What is Robertet SA's stock price today?
-
The Robertet SA share price today is $890.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RBTEF is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
RBTEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -17.59 | Sell |
Relative Strength Index (14 RSI): | 7.54 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (901.72 - 940.56) | Sell |
Bollinger Bands (100): | (884.68 - 998.56) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.09 | Sell |
Relative Strength Index (14 RSI): | 27.32 | Sell |
Chaikin Money Flow: | -6665822 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (89.04 - 110.5) | Sell |
Bollinger Bands (100): | (100.87 - 130.25) | Sell |
RBTEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 895.41 | Sell |
20-day SMA: | 918.11 | Sell |
50-day SMA: | 961.42 | Sell |
200-day SMA: | 918.11 | Sell |
8-day EMA: | 897.47 | Sell |
20-day EMA: | 914.57 | Sell |
50-day EMA: | 936.14 | Sell |
200-day EMA: | 926.79 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.79 | Sell |
20-day SMA: | 97.59 | Sell |
50-day SMA: | 103.71 | Sell |
200-day SMA: | 124.19 | Sell |
8-day EMA: | 88.23 | Sell |
20-day EMA: | 94.43 | Sell |
50-day EMA: | 103.04 | Sell |
200-day EMA: | 115.41 | Sell |
Robertet SA Earnings Growth & RBTEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.55 per share.
Robertet SA Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |